Zhang, L
Tai, Y-T
Ho, M
Xing, L
Chauhan, D
Gang, A
Qiu, L
Anderson, K C
Article History
First Online: 24 March 2017
Competing interests
: KCA serves on advisory boards to Millennium, Bristol Myers Squibb, and Gilead, and is a scientific founder of Oncopep and C4 Therapeutics. The remaining authors declare no competing financial interests.